Tuberculosis vaccines comprising antigens expressed during the latent infection phase

Details for Australian Patent Application No. 2011203012 (hide)

Owner Statens Serum Institut

Inventors Aagaard, Claus; Vingsbo-Lundberg, Carina; Andersen, Peter

Agent FB Rice

Pub. Number AU-A-2011203012

Parent 2006261445

Filing date 21 June 2011

Wipo publication date 14 July 2011

International Classifications

C07K 14/35 (2006.01) Peptides having more than 20 amino acids

A61K 39/04 (2006.01) Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

A61P 31/06 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

7 July 2011 Complete Application Filed

14 July 2011 Application Open to Public Inspection

  Published as AU-A-2011203012

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203013-Synthetic polysaccharide antigens for immunological intervention in disease

2011203011-Granulated metallic iron superior in rust resistance and method for producing the same